Bolivia cancer patients face drug shortages, out-of-pocket costs for immunotherapy

Bolivia's public health system (SUS) lacks essential cancer medications, forcing patients to pay out-of-pocket for treatments, with immunotherapy costs exceeding Bs 30,000. This highlights systemic gaps in oncology care access, potentially worsening health outcomes and financial strain. The extent of the shortage and government response remain unclear.